Pharmafile Logo

Creative BioStructure

Creative BioStructure is specialized in providing contract Structural Biology services to both academia and biotechnology/pharmaceutical industry. Featuring one of the most experienced teams in the field of Structural Biology, Creative BioStructure offers a full range of structural services, from molecular cloning to three-dimensional protein structure determination using X-ray Crystallography and NMR technology. Our expertise permits us to offer first class services in the most cost-effective manner.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

 Latest Content from PMHub 

Infographic: Keeping tracking on track

White Papers and Resources | December 7, 2016 | Inizio

Our best practice approach to tracking studies.

Lucid Group kick off their Winter Festival

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

What does the Five Year Forward View mean for pharma?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.

Healthcare in the Digital Age

White Papers and Resources | December 3, 2016 | M3 (EU)

Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

Press Releases | December 3, 2016 | M3 (EU)

M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs...

Telehealth Research

White Papers and Resources | December 1, 2016 | Inizio

The remote exchange of data between patients and their clinician

Leading Edge expands their senior medical writing team

Leading Edge, part of the Lucid Group specialising in strategic health communications and medical education, has bolstered its senior medical writing team with the new appointment of Jennifer (Jennie) Badger. Jennie...

Web Summit Lisbon: Technology trends that will impact pharma

Digital technology is transforming every aspect of life. Here’s the most important trends pharma companies should watch, as observed by Anthill at Websummit earlier this month:

Living with Crohn’s disease: a patient perspective

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for...

Lucid win PMEA Support Agency of the Year 2016

Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on...